DENTSPLY SIRONA Inc. (XRAY) › Analysis

DENTSPLY SIRONA Inc. (XRAY) analysis, March 17, 2026

Published March 17, 2026 · XRAY chart, levels and live analysis

Key Updates

DENTSPLY SIRONA declined -3.10% to $11.73 since the March 12 report, extending the correction phase that began after the February 28 peak. The stock now trades -20.09% below the $14.68 high reached in late February, demonstrating continued weakness despite positive industry tailwinds. The recent period brought two significant market reports: a diagnostic imaging market projection of $80 billion by 2034 and a digital dentistry market forecast showing 9.62% CAGR growth to $16.67 billion by 2031. While these reports confirm robust industry fundamentals, XRAY continues to underperform, suggesting company-specific execution challenges are overshadowing favorable market dynamics.

Current Trend

DENTSPLY SIRONA remains in a downtrend across most timeframes, with only a modest +2.62% YTD gain providing limited support for bulls. The stock has declined -8.36% over five days and -9.42% over one month, indicating sustained selling pressure. The six-month performance of -13.88% confirms a deteriorating technical structure. Price action since the February 28 rally peak has been decisively negative, with the stock unable to hold gains above $14.00 and subsequently breaking through the $13.45 and $12.61 support levels identified in previous reports. The current price of $11.73 represents a critical juncture, as further weakness could eliminate the remaining YTD gains and signal a return to multi-year lows. The persistent downward momentum despite positive industry forecasts suggests institutional investors remain skeptical about management's ability to execute the recovery strategy outlined in the Morningstar analysis.

Investment Thesis

The investment thesis centers on DENTSPLY SIRONA's turnaround potential as the company transitions from a closed proprietary Cerec ecosystem to an open platform strategy while operating in structurally growing dental markets. The digital dentistry market is projected to grow at 9.62% CAGR, expanding from $9.61 billion in 2025 to $16.67 billion by 2031, driven by technological advancements in CAD/CAM systems and increasing demand for cosmetic and restorative procedures. DENTSPLY SIRONA's strategic pivot to open its historically closed Cerec system and expand partnerships with competitors like 3Shape aims to capture a larger addressable market. The company maintains strong market positions across multiple dental segments, including leadership in dental burs and recognition in periodontal disease treatment markets. However, the thesis requires successful execution of the restructuring plan and market share stabilization in the competitive CAD/CAM segment where the company has lost ground over the past decade.

Thesis Status

The investment thesis remains under pressure as stock performance continues to diverge from positive industry fundamentals. While the overall dental market is projected to grow from $49.5 billion in 2023 to $87.1 billion by 2033 at 5.8% CAGR, DENTSPLY SIRONA's -13.88% six-month performance indicates the company is not yet capturing this growth. The strategic shift to an open platform represents the correct long-term direction, as evidenced by competitors' success with integrated workflows like the Henry Schein One and Align Technology iTero integration. However, the persistent stock weakness suggests investors are waiting for tangible evidence of market share stabilization and revenue acceleration before re-rating the equity. The thesis remains viable but requires demonstration of execution progress over the next 2-3 quarters to regain credibility. The company's presence in high-growth segments like digital dentistry and periodontal treatment provides optionality, but near-term headwinds from competitive pressures and the transition costs of opening the Cerec ecosystem continue to weigh on sentiment.

Key Drivers

Several industry-wide drivers support long-term growth potential. The digital dentistry market's 9.62% CAGR growth is driven by technological advancements in CAD/CAM systems, intraoral scanners, and 3D imaging solutions, with restorative dentistry holding 34.54% market share in 2025. The dental burs market expansion to $1.23 billion by 2033 reflects increasing volumes of restorative, cosmetic, and surgical dental procedures. The periodontal disease treatment market's growth to $3.86 billion by 2031 is fueled by rising prevalence of gum disorders and increased awareness of oral health's impact on overall health. Company-specific drivers include the strategic pivot to open the Cerec ecosystem and expand the 3Shape partnership, as detailed in the Morningstar recovery analysis. However, competitive dynamics remain challenging, as evidenced by partnerships like Leixir and Bite-Finder's AI-based collaboration and the Henry Schein-Align Technology integration that demonstrate the industry's rapid digital transformation.

Technical Analysis

DENTSPLY SIRONA's technical structure has deteriorated significantly since the February 28 peak of $14.68. The stock failed to hold the $13.45 support level identified in the March 6 report and subsequently broke through $12.61, establishing a pattern of lower highs and lower lows. The current price of $11.73 represents a -20.09% decline from the February high and sits precariously close to eliminating all YTD gains (+2.62%). The five-day decline of -8.36% indicates accelerating downward momentum, while the one-month loss of -9.42% confirms the trend. Volume patterns suggest sustained institutional selling rather than capitulation, as the decline has been orderly but persistent. Key resistance now stands at $12.61 (former support), with major resistance at $13.45 and $14.68. Immediate support lies at the $11.50 level, below which the stock could test the YTD breakeven around $11.43. The relative strength across timeframes (negative on 5-day, 1-month, and 6-month) indicates no immediate catalyst for reversal. A break below $11.50 would likely trigger additional selling and potentially test levels from late 2025.

Bull Case

Bear Case

Get a message when the XRAY picture changes — the agent team watches the levels and the news for you.Create a free account

More XRAY analyses